Vincent R. Anicetti, Chief Operating Officer at Coherus BioSciences, Inc. (CHRS), sold 10,000 shares at $19.56 ($196K) on 2020-01-17, disclosed to the SEC on 2020-01-22.
Open-market sale of $196k CHRS by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.56 | 5,000 | $98K | 49.9% |
| 2 | $19.57 | 2,500 | $49K | 25.0% |
| 3 | $19.69 | 2,500 | $49K | 25.1% |
| Total | $19.59 avg | 10,000 | $196K | 100% |
| Filing → |
| CHRS | SELL | 2021-01-21 | $45K | — | Filing → |
| CHRS | SELL | 2020-12-21 | $44K | — | Filing → |
| CHRS | SELL | 2020-12-09 | $324K | — | Filing → |